Research

An integrated research program from data to clinical evidence.

AI4Health connects heterogeneous health data and evidence with scalable computation and rigorous epidemiologic methods. We organize the program as a connected evidence system rather than a collection of isolated topics.

Research architecture

Three layers, one connected evidence system.

The same computational infrastructure can support multiple clinical questions, while the same clinical question can be examined across multiple evidence sources.

Layer 01Data & Evidence
Administrative health dataEHR & laboratory dataFAERS & Canada VigilanceDrug product monographsClinical trialsRegulatory documents
Layer 02Methods & Infrastructure
Machine learningExplainable AINLP & ontologiesCausal inferenceHigh-throughput computingAutomationVisual analyticsPrivacy-aware computation
Layer 03Clinical & Translational Applications
Medication safetyDrug-drug interactionsCKD & high-risk populationsClinical decision supportTrial generalizabilityPost-market surveillance
Core research areas

Where we concentrate our expertise.

01 · AI / XAI

AI & Explainable Machine Learning

Predictive modeling, interpretable machine learning and explanation methods that help researchers understand what a model learned, where it may fail and how predictions relate to clinical context.

02 · SCALE

High-Throughput Computing & Automation

Automated cohort generation, scalable computation and reusable pipelines that allow rigorous analyses to be repeated across many drugs, interactions, outcomes and populations.

03 · RWE

Drug Safety & Real-World Evidence

Population-based studies of medication safety and effectiveness using active-comparator designs, confounding control, sensitivity analyses and clinically meaningful outcomes.

04 · SAFETY

Pharmacovigilance & Safety Signals

Spontaneous-reporting systems, disproportionality analysis, terminology harmonization, missingness assessment and cross-source evidence to strengthen post-market safety surveillance.

05 · NLP

Drug Monographs & Regulatory Intelligence

NLP, MedDRA mapping, ontology-driven extraction and temporal or version-aware analysis of evolving drug monographs, labels and regulatory knowledge.

06 · VA

Visual Analytics & Research Software

Human-centred research software for high-dimensional EHRs, multimorbidity, feature-group discovery, laboratory-based prediction and pharmacovigilance data quality.

07 · TRIALS

Trials, Generalizability & Causal Methods

Assessing who is represented in trials, where evidence may not generalize, and how causal methods and target-trial emulation can strengthen treatment comparisons in routine care.

08 · TRUST

Reproducibility & Privacy-Aware Analytics

Provenance-aware workflows, standardized data processing, secure distributed analysis and computational practices that make large-scale health-data research more reproducible.

Interactive research explorer

Build an AI4Health research pathway.

Choose an evidence source, a method and an application. The explorer shows the research program that best connects them.

AI4Health pathway

Computational pharmacovigilance

Combining spontaneous-reporting evidence with interpretable computational methods can help prioritize safety questions, characterize reporting patterns and expose data-quality limitations before downstream inference.

Explore related projects →